To be eligible for this study, patients must meet several criteria, including but not limited to the following:
- Patients must have a solid tumor that has returned or progressed despite treatment.
- Patients must be age 18 or younger.
- At least 3 weeks must have passed since completion of prior chemotherapy (6 weeks since nitrosoureas) and 4 weeks since radiation therapy and entry into the study.
For more information and to inquire about eligibility for this study, please contact Dr. Ira Dunkel at 212-639-2153.